| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |